Exhibit 10.12
Myriad Pharmaceuticals,
Inc.
Management
Performance—Incentive Bonus Program
Fiscal Year 2010
The Compensation Committee of the
Board of Directors of Myriad Pharmaceuticals, Inc. has implemented
an annual management performance—incentive bonus program for
the purpose of establishing annual performance objectives for our
executives, including our named executive officers, to align their
performance with the overall goals and objectives for Myriad. This
process will commence in the fourth quarter of each fiscal year
with each executive meeting with our President and CEO to discuss
management business objectives (collectively “MBOs”)
for the ensuing fiscal year. After review and discussion, our
President and CEO will present the executive officers’ MBOs
to the Compensation Committee for final approval. Similarly, our
President and CEO meets with the Compensation Committee at the end
of each fiscal year to propose his MBOs for the ensuing fiscal year
which, after review and discussion, are finalized by the
Compensation Committee.
After the end of each fiscal year,
annual bonus awards will then be determined by the Compensation
Committee for each executive officer based on i) a target bonus
award opportunity, ii) the company’s overall financial
performance and financial condition, and iii) the individual
executive officer’s performance against the MBOs established
for such executive officer, the company’s financial
performanc
